Literature DB >> 8385656

Prognostic value of nucleolar organizer regions in neuroendocrine tumours of the lung.

J Böhm1, V Kacic, P Gais, H W Präuer, H Höfler.   

Abstract

The value of the number and size of the nucleolar organizer regions (NORs) as prognostic indicators in human neuroendocrine lung tumours was evaluated in a quantitative study of 57 cases, including 33 small cell carcinomas (SCLCs), 9 well-differentiated neuroendocrine carcinomas (WDNECs) and 15 "classic" carcinoids. NORs were visualized on paraffin sections by an argyrophilic technique (AgNOR) and measured by automatic image analysis. In each case, the mean number and area of AgNORs were evaluated; the results were compared with clinical follow-up and survival. AgNOR values for both number and area were significantly higher in SCLCs than in WDNECs and carcinoids. WDNECs had insignificantly higher AgNOR values than carcinoids. Among SCLCs, AgNOR values of the oat cell subtype and the intermediate cell subtype did not differ significantly. Regardless of the histological tumour type, AgNOR values strongly correlated with prognosis, with more and larger AgNORs indicating a more progressive clinical course. In the present study we demonstrate for the first time that the biological behaviour of neuroendocrine lung tumours is correlated with the number and size of AgNORs. Thus the measurement of AgNORs may serve as an additional prognostic indicator in these neoplasms, particularly in the separation of SCLCs from WDNECs with a more favourable prognosis.

Entities:  

Mesh:

Year:  1993        PMID: 8385656     DOI: 10.1007/bf00268025

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  34 in total

1.  Nucleolar organizer regions as a prognostic indicator for stage I non-small cell lung cancer.

Authors:  S Kaneko; T Ishida; K Sugio; H Yokoyama; K Sugimachi
Journal:  Cancer Res       Date:  1991-08-01       Impact factor: 12.701

2.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

Review 3.  Nucleolar organiser regions.

Authors:  J Crocker
Journal:  Curr Top Pathol       Date:  1990

4.  Correlation between NOR sizes and numbers in non-Hodgkin's lymphomas.

Authors:  J Crocker; M J Egan
Journal:  J Pathol       Date:  1988-11       Impact factor: 7.996

5.  Implication of nuclear morphological characteristics in small cell lung cancer.

Authors:  T K Lee; R D Horner; J F Silverman; D V Jackson; D Anderson-Goetz; C W Scarantino
Journal:  Anal Cell Pathol       Date:  1990-02       Impact factor: 2.916

6.  The histological spectrum of bronchial carcinoid tumours.

Authors:  P S Hasleton; N al-Saffar
Journal:  Appl Pathol       Date:  1989

Review 7.  Neuroendocrine neoplasms of the lung. A clinicopathologic update.

Authors:  W H Warren; L P Faber; V E Gould
Journal:  J Thorac Cardiovasc Surg       Date:  1989-09       Impact factor: 5.209

8.  Standardization of interphase Ag-NOR measurement by means of an automated image analysis system using lymphocytes as an internal control.

Authors:  M Derenzini; D Trerè
Journal:  J Pathol       Date:  1991-12       Impact factor: 7.996

9.  Ultrastructural organization of nucleoli in benign naevi and malignant melanomas.

Authors:  M Derenzini; C M Betts; C Ceccarelli; V Eusebi
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

Review 10.  Nucleolar organiser regions in pathology.

Authors:  M J Egan; J Crocker
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

View more
  2 in total

Review 1.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

2.  Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.

Authors:  R M Przygodzki; S D Finkelstein; J C Langer; P A Swalsky; N Fishback; A Bakker; D G Guinee; M Koss; W D Travis
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.